From: Prion strains associated with iatrogenic CJD in French and UK human growth hormone recipients
Isolate number | Codon 129 | PrPres type | Origin | Brain area | TgMet129 | TgVal129 | Identified strain(s) | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Passage 1 | Passage 2 | Passage 1 | Passage 2 | ||||||||||
Survival time | PrPres type | Survival time | PrPres type | Survival time | PrPres type | Survival time | PrPres type | ||||||
23 | MM | 1 | Fr | Frontal cortex | 230 ± 13 | 1 | 201 ± 11 | 1 | 336 ± 8 | 1 | 284 ± 5 | 1 | M1CJD |
24 | MM | 1 | UK | Frontal cortex | 226 ± 4 | 1 | ND | 326 ± 9 | ND | M1CJD | |||
25 | MV | 1 | Fr | Frontal cortex | 276 ± 19 | 1 | 205 ± 7 | 1 | 296 ± 13 | 1 | 282 ± 9 | 1 | M1CJD |
26 | MV | 1 | UK | Frontal cortex | 197 ± 6 | 1 | 209 ± 17 | 1 | 289 ± 13 | 1 | 289 ± 8 | 1 | M1CJD |
27 | MV | 1 | Fr | Frontal cortex | 205 ± 16 | 1 | 220 ± 13 | 1 | 258 ± 33 | 2 | 184 ± 6 | 2 | M1CJD + V2CJD |
28 | MV | 2 | UK | Frontal cortex | 470 ± 23 | 1 | 211 ± 12 | 1 | 184 ± 9 | 2 | 180 ± 6 | 2 | M1CJD + V2CJD |
29 | MV | 2 | Fr | Frontal cortex | 375 ± 45 | 1 | 205 ± 5 | 1 | 251 ± 66 | 2 | 168 ± 3 | 2 | M1CJD + V2CJD |
30 | MV | 2 | UK | Frontal cortex | 578 ± 28 | 1 | 492 ± 70 | 1 | 219 ± 17 | 2 | 174 ± 3 | 2 | V2CJD |
31 | MV | 2 | Fr | Caudate | 518 ± 84 | 1 | 571 ± 14 | 1 | 180 ± 8 | 2 | 161 ± 8 | 2 | V2CJD |
32 | VV | 2 | Fr | Frontal cortex | 626 ± 85 | 1 | 548 ± 24 | 1 | 198 ± 7 | 2 | 170 ± 7 | 2 | V2CJD |
33 | VV | 2 | Fr | Frontal cortex | 521 ± 65 | 1 | 216 ± 1 | 1 | 188 ± 13 | 2 | 166 ± 6 | 2 | M1CJD + V2CJD |